Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BARCLAY G CARAS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1346265592
CMS profile
16189
Location
NORWICH, CT

General Payments · PY2018–2024

$3,388.36

  • Reported across 148 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$736.33

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $736.33 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $440.51 20
ABBVIE INC. $162.26 12
Otsuka America Pharmaceutical, Inc. $111.71 1
Neurocrine BioSciences, Inc. $21.85 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $618.95 13
PY2019 $639.99 37
PY2020 $223.27 14
PY2021 $133.86 4
PY2022 $283.49 13
PY2023 $752.47 33
PY2024 $736.33 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.15 01/02/2024 Food and Beverage Undisputed 01/23/2026 1103414765 CMS
ABBVIE INC. $15.44 01/23/2024 Food and Beverage Undisputed 01/23/2026 1103414767 CMS
ABBVIE INC. $14.52 02/06/2024 Food and Beverage Undisputed 01/23/2026 1103414769 CMS
ABBVIE INC. $15.28 02/27/2024 Food and Beverage Undisputed 01/23/2026 1103414771 CMS
ABBVIE INC. $16.52 03/12/2024 Food and Beverage Undisputed 01/23/2026 1103414773 CMS
ABBVIE INC. $4.83 03/29/2024 Food and Beverage Undisputed 01/23/2026 1103414775 CMS
ABBVIE INC. $12.37 04/02/2024 Food and Beverage Undisputed 01/23/2026 1103414777 CMS
ABBVIE INC. $15.41 05/31/2024 Food and Beverage Undisputed 01/23/2026 1103414779 CMS
ABBVIE INC. $16.58 06/11/2024 Food and Beverage Undisputed 01/23/2026 1103414781 CMS
ABBVIE INC. $15.57 10/29/2024 Food and Beverage Undisputed 01/23/2026 1103414783 CMS
ABBVIE INC. $10.63 11/19/2024 Food and Beverage Undisputed 01/23/2026 1103414785 CMS
ABBVIE INC. $8.96 12/17/2024 Food and Beverage Undisputed 01/23/2026 1103414787 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.84 01/04/2024 Food and Beverage Undisputed 01/23/2026 1143202994 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.83 01/17/2024 Food and Beverage Undisputed 01/23/2026 1143202998 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.94 02/23/2024 Food and Beverage Undisputed 01/23/2026 1143203001 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $127.35 03/19/2024 Food and Beverage Undisputed 01/23/2026 1143203005 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.89 03/25/2024 Food and Beverage Undisputed 01/23/2026 1143203009 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.85 04/04/2024 Food and Beverage Undisputed 01/23/2026 1143203012 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.56 04/17/2024 Food and Beverage Undisputed 01/23/2026 1143203016 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.42 04/29/2024 Food and Beverage Undisputed 01/23/2026 1143203020 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.89 05/13/2024 Food and Beverage Undisputed 01/23/2026 1143203023 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.62 05/28/2024 Food and Beverage Undisputed 01/23/2026 1143203027 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $108.25 06/18/2024 Food and Beverage Undisputed 01/23/2026 1143203031 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.29 06/27/2024 Food and Beverage Undisputed 01/23/2026 1143203035 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8.31 07/08/2024 Food and Beverage Undisputed 01/23/2026 1143203038 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.39 08/13/2024 Food and Beverage Undisputed 01/23/2026 1143203042 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.35 09/04/2024 Food and Beverage Undisputed 01/23/2026 1143203046 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.08 10/25/2024 Food and Beverage Undisputed 01/23/2026 1143203050 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.35 10/30/2024 Food and Beverage Undisputed 01/23/2026 1143203053 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.35 11/12/2024 Food and Beverage Undisputed 01/23/2026 1143203058 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.60 12/03/2024 Food and Beverage Undisputed 01/23/2026 1143203062 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.35 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143203065 CMS
Neurocrine Biosciences, Inc. $21.85 07/18/2024 Food and Beverage Undisputed 01/23/2026 1150851936 CMS
Otsuka America Pharmaceutical, Inc. $111.71 05/09/2024 Food and Beverage Undisputed 01/23/2026 1118871452 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.